An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study). (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202107-1779oc
PubMed Identifier: 35175905
Publication URI: http://europepmc.org/abstract/MED/35175905
Type: Journal Article/Review
Volume: 205
Parent Publication: American journal of respiratory and critical care medicine
Issue: 10
ISSN: 1073-449X